NPRA looks into Sinovac's application for use on children, says MOH
After Pfizer, the National Pharmaceutical Regulatory Agency (NPRA) is now looking into Sinovac's application for the vaccine to be used on adolescents in the country.
According to the Health Ministry, the Beijing-based pharmaceutical company has submitted its dossier recently to seek the agency's approval.
"Yes, Sinovac has submitted. They (NPRA) are now...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable